The role of JNK in the development of hepatocellular carcinoma

Genes and Development

Volumn 25, Issue 6, 2011, Pages 634-645

  Das, Madhumita ^a   Garlick, David S ^a   Greiner, Dale L ^a   Davis, Roger J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Hepatocellular carcinoma; JNK; Partial hepatectomy

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME DEFICIENCY; HEPATITIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOKINES; HEPATOCYTES; INTERLEUKIN-6; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 79952595097     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1989311     Document Type: Article

References (49)

1. Behrens A, Sibilia M, Wagner EF. 1999. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21: 326-329. (Pubitemid 29124945)
2. Behrens A, Sibilia M, David JP, Mohle-Steinlein U, Tronche F, Schutz G, Wagner EF. 2002. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 21: 1782-1790. (Pubitemid 34614634)
3. Belgardt BF, Mauer J, Wunderlich FT, Ernst MB, Pal M, Spohn G, Bronneke HS, Brodesser S, Hampel B, Schauss AC, et al. 2010. Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc Natl Acad Sci 107: 6028-6033.
4. Cabrita MA, Christofori G. 2008. Sprouty proteins, master-minds of receptor tyrosine kinase signaling. Angiogenesis 11: 53-62.
5. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. 2007. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13: 851-856. (Pubitemid 47038190)
6. Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE. 2008. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173: 856-864.
7. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274: 1379-1383. (Pubitemid 26391463)
8. Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci 104: 15759-15764. (Pubitemid 350035373)
9. Das M, Sabio G, Jiang F, Rincon M, Flavell RA, Davis RJ. 2009. Induction of hepatitis by JNK-mediated expression of TNF-α. Cell 136: 249-260.
10. Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
11. Eferl R, Wagner EF. 2003. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868. (Pubitemid 37383716)
12. Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, Wagner EF. 2003. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112: 181-192. (Pubitemid 36144108)
13. Fausto N. 1999. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 19: 243-252. (Pubitemid 29488767)
14. Greene AK, Puder M. 2003. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 16: 99-102. (Pubitemid 36609041)
15. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158. (Pubitemid 46398669)
16. Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell 140: 883-899.
17. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386: 296-299. (Pubitemid 27142517)
18. Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF. 2008. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 down-regulation. J Clin Invest 118: 3943-3953.
19. Jazbutyte V, Thum T. 2010. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 11: 926-935.
20. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD. 2008. Association of micro-RNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427. (Pubitemid 351226109)
21. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, et al. 2010. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
22. Kiba T. 2002. The role of the autonomic nervous system in liver regeneration and apoptosis-recent developments. Digestion 66: 79-88. (Pubitemid 35356687)
23. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22: 667-676. (Pubitemid 29203491)
24. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269: 1427-1429.
25. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K. 2006. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678. (Pubitemid 44521987)
26. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. 2003. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 11: 1479-1489. (Pubitemid 36776535)
27. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, et al. 2007. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333. (Pubitemid 47281433)
28. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. 2005. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990. (Pubitemid 40884391)
29. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE. 1996. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci 93: 12908-12913. (Pubitemid 26382742)
30. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
31. Mikkola HK, Klintman J, Yang H, Hock H, Schlaeger TM, Fujiwara Y, Orkin SH. 2003. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421: 547-551. (Pubitemid 36168449)
32. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP. 2009. Liver stem cells and hepatocellular carcinoma. Hepatology 49: 318-329.
33. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124. (Pubitemid 47056470)
34. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. 2010. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208.
35. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315. (Pubitemid 29035064)
36. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426.
37. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543.
38. Sabio G, Cavanagh-Kyros J, Barrett T, Jung DY, Ko HJ, Ong H, Morel C, Mora A, Reilly J, Kim JK, et al. 2010. Role of the hypothalamic-pituitary- thyroid axis in metabolic regulation by JNK1. Genes Dev 24: 256-264.
39. Sakurai T, Maeda S, Chang L, Karin M. 2006. Loss of hepatic NF-κ B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci 103: 10544-10551. (Pubitemid 44078014)
40. Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, Karin M. 2008. Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14: 156-165.
41. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. 1999. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 13: 607-619. (Pubitemid 29131884)
42. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, Brenner DA. 2003. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37: 824-832. (Pubitemid 36397393)
43. Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF. 2006. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev 20: 2306-2314.
44. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874. (Pubitemid 30257738)
45. Ventura JJ, Kennedy NJ, Lamb JA, Flavell RA, Davis RJ. 2003. c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol Cell Biol 23: 2871-2882. (Pubitemid 36403084)
46. Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
47. Westwick JK, Weitzel C, Leffert HL, Brenner DA. 1995. Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 95: 803-810.
48. Whitmarsh AJ, Davis RJ. 2007. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26: 3172-3184. (Pubitemid 46763013)
49. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9: 575-585.